Ajani JA - Search Results

1

Anti-angiogenic agent ramucirumab: meaningful or marginal?

Wadhwa R, Elimova E, Shiozaki H, Sudo K, Blum MA, Estrella JS, Chen Q, Song S, Ajani JA. Wadhwa R, et al. Among authors: ajani ja. Expert Rev Anticancer Ther. 2014 Apr;14(4):367-79. doi: 10.1586/14737140.2014.896207. Epub 2014 Mar 7. Expert Rev Anticancer Ther. 2014. PMID: 24605771 Review.

2

Preoperative and adjuvant therapies for upper gastrointestinal cancers.

Varadhachary G, Ajani JA. Varadhachary G, et al. Among authors: ajani ja. Expert Rev Anticancer Ther. 2005 Aug;5(4):719-25. doi: 10.1586/14737140.5.4.719. Expert Rev Anticancer Ther. 2005. PMID: 16111471 Review.

3

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.

Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu XC. Song S, et al. Among authors: ajani ja. Oncogene. 2005 Dec 15;24(56):8268-76. doi: 10.1038/sj.onc.1208992. Oncogene. 2005. PMID: 16170369

4

Evolving chemotherapy for advanced gastric cancer.

Ajani JA. Ajani JA. Oncologist. 2005;10 Suppl 3:49-58. doi: 10.1634/theoncologist.10-90003-49. Oncologist. 2005. PMID: 16368871 Free article. Review.

5

Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.

Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Estrella JS, et al. Among authors: ajani ja. Am J Surg Pathol. 2011 Jul;35(7):1045-53. doi: 10.1097/PAS.0b013e318219ccef. Am J Surg Pathol. 2011. PMID: 21602659

6

Celebrate or calibrate? We say calibrate.

Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SG. Ajani JA, et al. J Clin Oncol. 2011 Jul 1;29(19):2732; author reply 2732-3. doi: 10.1200/JCO.2011.35.7962. Epub 2011 May 23. J Clin Oncol. 2011. PMID: 21606421 No abstract available.

7

A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.

Blum M, Suzuki A, Ajani JA. Blum M, et al. Among authors: ajani ja. Future Oncol. 2011 Jun;7(6):715-26. doi: 10.2217/fon.11.50. Future Oncol. 2011. PMID: 21675835 Review.

8

Many a mickle makes a muckle. Translating a gastric cancer phenotype into a bigger thing.

Blum MA, Ajani JA. Blum MA, et al. Among authors: ajani ja. Onkologie. 2011;34(10):499-500. doi: 10.1159/000332331. Epub 2011 Sep 16. Onkologie. 2011. PMID: 21985847 No abstract available.

9

Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy.

Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Suzuki A, et al. Among authors: ajani ja. Oncology. 2012;82(2):108-13. doi: 10.1159/000335951. Epub 2012 Feb 11. Oncology. 2012. PMID: 22328056

10

Gastric cancer: apples will always be apples.

Ajani JA, Blum MA, Estrella JS, Das P, Fournier KF. Ajani JA, et al. J Clin Oncol. 2012 Mar 20;30(9):1017-8; author reply 1019-20. doi: 10.1200/JCO.2011.40.9607. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331947 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

798 results

Search Page

Filters